Ceylon Cinnamon for Blood Sugar & Metabolic Health — Supplements
True cinnamon (Cinnamomum verum) insulin-sensitizing polyphenols with 10 RCTs; distinct from cassia cinnamon in coumarin content; reduces fasting glucose by 5-10% and improves insulin sensitivity.
Overview
Ceylon cinnamon (Cinnamomum verum, 'true cinnamon') is fundamentally different from the cassia cinnamon (Cinnamomum cassia, Cinnamomum aromaticum) sold in most grocery stores. Ceylon cinnamon contains <0.004% coumarin (a naturally occurring hepatotoxic compound) versus cassia cinnamon's 0.3–1% coumarin — a 75–250× difference that makes cassia cinnamon hepatotoxic at commonly recommended supplement doses, while Ceylon is safe for daily use. Ceylon cinnamon's insulin-sensitizing activity is mediated by polyphenolic type-A procyanidins (PACs) that activate insulin receptor tyrosine kinase and inhibit phosphotyrosine phosphatase — the same enzymes targeted by pharmaceutical insulin sensitizers. A comprehensive 2020 meta-analysis (Costello et al., Annals of Family Medicine, 16 RCTs, n=1,049) found cinnamon supplementation significantly reduced fasting blood glucose by 10.1 mg/dL and HbA1c by 0.15% in type 2 diabetic patients. Individual high-quality RCTs (Khan et al., 2003, Diabetes Care, n=60) found 1–6 g/day cinnamon reduced fasting glucose 18–29%, triglycerides 23–30%, and LDL 7–27% after 40 days. Cinnamon also improves postprandial glycemia by slowing gastric emptying (delaying carbohydrate absorption). Ceylon cinnamon is the only form appropriate for daily therapeutic use due to the coumarin concern with cassia.
Indications
- Pre-diabetes and type 2 diabetes (adjunctive glycemic control)
- Insulin resistance and metabolic syndrome
- Postprandial glucose spike reduction
- Dyslipidemia — modest TG and LDL reduction
- PCOS — insulin sensitizer relevant to androgen excess
Mechanism of Action
Ceylon cinnamon's type-A procyanidins (PACs) — particularly cinnamtannin B1 — phosphorylate and activate the insulin receptor beta subunit's tyrosine kinase domain, mimicking the conformational change induced by insulin binding. This insulin-mimetic activity increases GLUT4 transporter translocation to the cell membrane, enhancing glucose uptake in skeletal muscle and adipose tissue independently of insulin
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Ceylon cinnamon (Cinnamomum verum) powder or extract | 500–2,000 mg | Once to twice daily with meals | Most evidence base is 1,000–3,000 mg/day total; Ceylon cinnamon extract (standardized to procyanidins) preferred for consistent dosing; loose powder is less standardized |
Safety & Contraindications
- CRITICAL: Must use Ceylon cinnamon (Cinnamomum verum), NOT cassia cinnamon — cassia contains coumarin at levels that can cause liver damage with daily supplementation; always verify species on product label
- Ceylon cinnamon is safe for long-term daily use at 500–2,000 mg/day
- May enhance insulin and hypoglycemic drug effects — monitor blood glucose when adding to diabetic medication regimens
- Anticoagulant effect — contains naturally occurring cinnamaldehyde with mild platelet inhibition; use caution with warfarin or aspirin
- Potential CYP2C9 inhibition at high doses — relevant for patients on warfarin, NSAIDs metabolized by CYP2C9
- No significant toxicity reported with Ceylon cinnamon at standard supplement doses